CTNI-25. PHASE IB CLINICAL TRIAL OF CHRONIC CONVECTION-ENHANCED DELIVERY OF TOPOTECAN FOR RECURRENT GLIOBLASTOMA

OBJECTIVES: Convection-enhanced delivery (CED) provides pharmacokinetic advantages over systemic delivery for achieving cytotoxic drug levels into targeted regions of the brain. A major shortcoming of CED has been the need to limit treatment duration because of infection risks associated with extern...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Bruce, Jeffrey, Spinazzi, Eleonora, Lassman, Andrew, Iwamoto, Fabio, Welch, Mary, Banu, Matei, Argenziano, Michael, Upadhyayula, Pavan, Agar, Nathalie Y R, Humala, Nelson, Marie, Tamara, Pereira, Brianna, Sudhakar, Tejaswi, Mahajan, Aayushi, Neira, Justin, Lignelli-Dipple, Angela, Grinband, Jack, Sims, Peter, D’Amico, Randy, Canoll, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Trials: Non-Immunologic
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650341/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados